Theravance Biopharma, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
George Town, Grand Cayman, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Theravance Biopharma, Inc. has filed 1,125 SEC EDGAR filings since 01 Aug 2013

SEC filing history

Showing 276-300 of 1,000 matching filings.

Per page
25
Current page
12
4

4 filing

Filing date
22 Feb 2023
Reporting date
20 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Feb 2023
Reporting date
20 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Feb 2023
Reporting date
20 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Feb 2023
Reporting date
20 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Feb 2023
Reporting date
20 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
22 Feb 2023
Reporting date
14 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88552

AMENDMENT NO. 2

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88552

SC 13G/A filing

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88552

NONE

Filing date
13 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88552

SC 13G/A filing

Filing date
10 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88552

SC 13G/A filing

Filing date
10 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88552

SCHEDULE 13G/A

Filing date
09 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88552

SC 13G filing

Filing date
30 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
10 Jan 2023
Reporting date
01 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Dec 2022
Reporting date
14 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Dec 2022
Reporting date
01 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
23 Nov 2022
Reporting date
22 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-I/A File 005-88552

SC TO-I/A

Filing date
22 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Nov 2022
Reporting date
20 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Nov 2022
Reporting date
18 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Nov 2022
Reporting date
20 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Nov 2022
Reporting date
20 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-I/A File 005-88552

SC TO-I/A

Filing date
18 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .